Start for free
Start for free
Marshall Wace logo

Marshall Wace

Europe, England, United Kingdom, London

Description

Marshall Wace is a global asset manager that offers a diverse range of investors alternative investment solutions.

Investor Profile

Marshall Wace has made 61 investments, with 12 in the past 12 months and 26% as lead.

Stage Focus

  • Series B (21%)
  • Series C (21%)
  • Post Ipo Equity (16%)
  • Series E (11%)
  • Series Unknown (8%)
  • Series D (7%)
  • Series A (5%)
  • Private Equity (5%)
  • Series F (3%)
  • Seed (2%)

Country Focus

  • United States (77%)
  • India (8%)
  • Switzerland (5%)
  • United Kingdom (3%)
  • Canada (3%)
  • Singapore (2%)
  • Israel (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Financial Services
  • Fintech
  • Pharmaceutical
  • Therapeutics
  • Medical
  • Life Science
  • Blockchain
  • Cryptocurrency
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Marshall Wace frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 9
venBio Partners
venBio Partners
North America, California, United States, San Francisco
Co-Investments: 7
Surveyor Capital
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 10
Samsara BioCapital
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 6
RTW Investments
RTW Investments
North America, New York, United States, New York
Co-Investments: 8
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 10
BlackRock
BlackRock
North America, New York, United States, New York
Co-Investments: 6
Soleus Capital
Soleus Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 8
Logos Capital
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 10
Janus Henderson Investors
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 11

Which angels does Marshall Wace often collaborate with?

Uday Kumar Bangalore Shivaraman
Uday Kumar Bangalore Shivaraman
Asia, Karnataka, India, Bengaluru
Shared Deals: 1
PL
Pierre Lamond
North America, California, United States, Palo Alto
Shared Deals: 1
FS
Frank Slootman
North America, California, United States, Santa Clara
Shared Deals: 1
AG
Alex Gorsky
North America, New Jersey, United States, New Brunswick
Shared Deals: 1
EC
Emilie Choi
North America, California, United States, San Francisco
Shared Deals: 1
CC
Caesar Chad
North America, California, United States, San Jose
Shared Deals: 1
MS
Michael Scarpelli
North America, California, United States, San Francisco
Shared Deals: 1
BT
Belinda Termeer
North America, Massachusetts, United States, Marblehead
Shared Deals: 1
MJ
Shared Deals: 1

What are some of recent deals done by Marshall Wace?

Rezolute

Louisville, Colorado, United States

Rezolute is a clinical-stage biopharma specializing in the development of drug therapies for patients with metabolic and orphan diseases.

BiotechnologyDiabetesHealth CareTherapeutics
Post Ipo EquityApr 23, 2025
Amount Raised: $96,900,000
Attovia Therapeutics

San Carlos, California, United States

Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.

BiotechnologyHealth CareMedicalTherapeutics
Series CApr 15, 2025
Amount Raised: $90,000,000
Sammaan Capital

Mumbai, Maharashtra, India

Sammaan Capital offers home loans in the affordable housing segment.

CreditFinancial ServicesLendingReal Estate
Post Ipo EquityJan 27, 2025
Amount Raised: $151,179,028
Aviceda Therapeutics

Cambridge, Massachusetts, United States

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics
Series CJan 7, 2025
Amount Raised: $207,500,000
35Pharma

Montreal, Quebec, Canada

35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need.

BiopharmaBiotechnologyPharmaceutical
Series CNov 26, 2024
Amount Raised: $53,000,000
Beta Bionics

Irvine, California, United States

Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.

BiotechnologyDiabetesMedical Device
Series ENov 13, 2024
Amount Raised: $60,000,000
Inquis Medical

Redwood City, California, United States

Inquis Medical is developing thrombectomy technology, enabling an efficient single-pass thrombectomy with minimal blood loss.

Health CareMedical
Series BNov 4, 2024
Amount Raised: $40,000,000
Evommune

Palo Alto, California, United States

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

BiotechnologyHealth CareLife Science
Series COct 31, 2024
Amount Raised: $115,000,000
Elektrofi

Boston, Massachusetts, United States

Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.

Alternative MedicineBiotechnologyTherapeutics
Series CAug 22, 2024
Amount Raised: $112,250,000
Pathalys Pharma

Raleigh, North Carolina, United States

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

BiopharmaBiotechnology
Series BAug 20, 2024
Amount Raised: $105,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator